−0.160CAD
−14.86 MCAD
4.94 MCAD
109.94 M
About STAGEZERO LIFE SCIENCES LTD
Sector
Industry
CEO
James R. Howard-Tripp
Website
Headquarters
Richmond Hill
Employees (FY)
40
Founded
1997
FIGI
BBG000BDF4S3
StageZero Life Sciences Ltd. engages in the development and commercialization of proprietary molecular diagnostic tests for detection of diseases and for personalized health management, with a focus on cancer-related indications. Its products includes Sentinel Principle, and ColonSentry. The company was founded by Choong-Chin Liew and K. Wayne Marshall on February 20, 1997 and is headquartered in Richmond Hill, Canada.
SZLS Trending Higher This stock has a huge potential and the chart has demonstrated that for the last 6 months. This recent activity bodes well for news about there Aristotle testing application for Cancer. From the market action, we should expect a doubling of the price in the near term. IF the news is good enough
SZLS $6 TARGETEvery indicator on this stock indicates we bottomed and moving up
Easy selection for the 1st Qtr 2021
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of SZLS is 0.040 CAD — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TSX exchange STAGEZERO LIFE SCIENCES LTD stocks are traded under the ticker SZLS.
STAGEZERO LIFE SCIENCES LTD is going to release the next earnings report on May 15, 2024. Keep track of upcoming events with our Earnings Calendar.
SZLS stock is 0% volatile and has beta coefficient of 0.48. Check out the list of the most volatile stocks — is STAGEZERO LIFE SCIENCES LTD there?
STAGEZERO LIFE SCIENCES LTD revenue for the last quarter amounts to 511.17 K CAD despite the estimated figure of 2.50 M CAD. In the next quarter revenue is expected to reach 2.75 M CAD.
Yes, you can track STAGEZERO LIFE SCIENCES LTD financials in yearly and quarterly reports right on TradingView.
SZLS stock hasn't changed in a week, the month change is a 11.11% fall, over the last year STAGEZERO LIFE SCIENCES LTD has showed a 50.00% decrease.
SZLS net income for the last quarter is −1.10 M CAD, while the quarter before that showed −539.29 K CAD of net income which accounts for −104.41% change. Track more STAGEZERO LIFE SCIENCES LTD financial stats to get the full picture.
Today STAGEZERO LIFE SCIENCES LTD has the market capitalization of 4.92 M, it has decreased by 5.00% over the last week.
No, SZLS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, SZLS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade STAGEZERO LIFE SCIENCES LTD stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 24, 2024, the company has 40.00 employees. See our rating of the largest employees — is STAGEZERO LIFE SCIENCES LTD on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So STAGEZERO LIFE SCIENCES LTD technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating STAGEZERO LIFE SCIENCES LTD stock shows the sell signal. See more of STAGEZERO LIFE SCIENCES LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. STAGEZERO LIFE SCIENCES LTD EBITDA is −5.82 M CAD, and current EBITDA margin is −194.90%. See more stats in STAGEZERO LIFE SCIENCES LTD financial statements.